![Arie Belldegrun](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arie Belldegrun
Gründer bei
ALLOGENE THERAPEUTICS, INC.
Vermögen: 27 Mio $ am 30.06.2026
Profil
Arie S. Belldegrun ist ein Unternehmer und Geschäftsmann, der 6 Firmen gegründet hat, darunter: Kite Pharma, Inc, Allogene Therapeutics, Inc. und Agensys, Inc. und der an der Spitze von 16 verschiedenen Unternehmen stand. Derzeit ist er Vorsitzender & Partner bei Two River Group Holdings LLC, Vorsitzender bei Two River Group Management LLC, Vorsitzender bei Bellco Capital LLC (die er 2003 gründete), Vorsitzender bei Two Rivers Consulting Corp. und bei UroGen Pharma Ltd. (die er 2017 gegründet hat), Chairman von Kronos Bio, Inc. und Co-Chairman bei Breakthrough Properties LLC, Senior Managing Director bei VV Manager LLC (die er 2017 gegründet hat), Senior Managing Director bei Vida Ventures LLC (die er 2017 gegründet hat) (eine Tochtergesellschaft von VV Manager LLC) und Chairman der Technology Assessment Group. Arie S. Belldegrun ist außerdem Direktor & Professor am UCLA Institute of Urologic Oncology, Leiter der Abteilung für urologische Onkologie an der David Geffen School of Medicine und Senior Managing Director bei Vida Ventures LLC (die er 2017 gegründet hat) und im Vorstand von 5 weiteren Unternehmen. Dr. Belldegrun war zuvor Chairman von Arno Therapeutics, Inc. und Non-Executive Chairman bei Arno Therapeutics, Inc. (eine Tochtergesellschaft von Arno Therapeutics, Inc.), Chairman, President & Chief Executive Officer bei Equinor ASA, Director bei Agensys, Inc. (er gründete das Unternehmen im Jahr 1997), Executive Chairman, President & CEO bei Kite Pharma, Inc. (er gründete das Unternehmen 2009), Chairman-Molecular Biological Technology Committee bei American Urological Association Education & Research, Inc., Forscher am National Cancer Institute und Mitglied des Los Angeles Economy & Jobs Committee. Arie S. Belldegrun promovierte an der Hadassah Medical School der Hebräischen Universität und erwarb einen Abschluss am Weizmann Institute of Science.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
UROGEN PHARMA LTD. 0.84% | 22.06.2026 | 408’693 ( 0.84% ) | 15 Mio $ | 30.06.2026 |
| 31.03.2026 | 5’537’887 ( 1.6% ) | 12 Mio $ | 30.06.2026 |
Aktive Positionen von Arie Belldegrun
| Unternehmen | Position | Beginn |
|---|---|---|
| UROGEN PHARMA LTD. | Vorsitzender | 01.10.2012 |
| ALLOGENE THERAPEUTICS, INC. | Gründer | 01.11.2017 |
Fosun Kite Biotechnology Co., Ltd.
 Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Direktor/Vorstandsmitglied | - |
Breakthrough Properties LLC
 Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC is an active manager. | Vorsitzender | 01.06.2018 |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Gründer | 01.01.2017 |
ByHeart, Inc.
 ByHeart, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Develops nutrition infant formula products based on breast milk | Direktor/Vorstandsmitglied | 01.10.2019 |
105 W First Street LLC
 105 W First Street LLC Real Estate Investment TrustsFinance Provides real estate investment trusts and financial services | Direktor/Vorstandsmitglied | - |
Bellco Capital LLC
 Bellco Capital LLC Investment ManagersFinance Bello Capital invests in companies located in the United States. The firm targets companies operating in the life science, real estate, consumer products, and media sectors. It provides financing for later stage capital requirements. | Gründer | 01.01.2004 |
David Geffen School of Medicine
 David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2000 |
| ░░░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Arie Belldegrun
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Arie Belldegrun
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
43
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 43 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Email Real Estate.com, Inc.
 Email Real Estate.com, Inc. Financial ConglomeratesFinance Development stage company | Finance |
Equinor ASA
 Equinor ASA Integrated OilEnergy Minerals Engages in production, exploration and marketing of oil & natural gas and generates wind power | Energy Minerals |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group invests in companies located in the United States. The firm focuses on life sciences and healthcare sectors. It participates in early stage capital requirements. | Finance |
Paramount Acquisition Corp.
 Paramount Acquisition Corp. Financial ConglomeratesFinance Investment vehicle acquiring operating businesses in the healthcare industry | Finance |
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Arno Therapeutics, Inc. /Old/
 Arno Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical to treat cancer | Health Technology |
Technology Assessment Group
 Technology Assessment Group Miscellaneous Commercial ServicesCommercial Services Provides research and evaluation services for the effects of drug therapies | Commercial Services |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines for cancers | Commercial Services |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Urological Association Education & Research, Inc.
 American Urological Association Education & Research, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a urologic association | Commercial Services |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Los Angeles Economy & Jobs Committee | |
Sonablate Corp.
 Sonablate Corp. Medical SpecialtiesHealth Technology Develops and manufactures high intensity focused ultrasound surgical ablation systems | Health Technology |
Arno Therapeutics, Inc.
 Arno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs | Health Technology |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Bioscience for the State of California | |
Bellco Capital LLC
Bellco Capital LLC Investment ManagersFinance Bello Capital invests in companies located in the United States. The firm targets companies operating in the life science, real estate, consumer products, and media sectors. It provides financing for later stage capital requirements. | Finance |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
UCLA Institute of Urologic Oncology | |
David Geffen School of Medicine
David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
The Hebrew University Hadassah Medical School
 The Hebrew University Hadassah Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The American Association of Genitourinary Surgeons
 The American Association of Genitourinary Surgeons Miscellaneous Commercial ServicesCommercial Services Operates as an urologist association | Commercial Services |
Ginkgo Bioworks, Inc.
 Ginkgo Bioworks, Inc. Miscellaneous Commercial ServicesCommercial Services Builds autonomous labs to accelerate R&D in biotechnology | Commercial Services |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Develops disruptive cell-based therapies for cancer and other devastating diseases | Health Technology |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Health Technology |
The Parker Institute For Cancer Immunotherapy
 The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services Operates cancer research | Commercial Services |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
VV Manager LLC
VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
ByHeart, Inc.
ByHeart, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Develops nutrition infant formula products based on breast milk | Consumer Non-Durables |
105 W First Street LLC
105 W First Street LLC Real Estate Investment TrustsFinance Provides real estate investment trusts and financial services | Finance |
Breakthrough Properties LLC
Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC is an active manager. | Finance |
Breakthrough Services LLC
 Breakthrough Services LLC Breakthrough Services LLC is an assisted living facility. The company is based in New York. | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Health Technology |
Soaring Eagle Acquisition Corp.
 Soaring Eagle Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Ginkgo Bioworks Holdings, Inc.
 Ginkgo Bioworks Holdings, Inc. Medical/Nursing ServicesHealth Services Develops biological engineering products and custom microbes | Health Services |
D3C1 Allston Co-Investment LP
 D3C1 Allston Co-Investment LP Financial ConglomeratesFinance Functions as investment fund | Finance |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology Develops transformational therapies for patients with life-threatening disease | Health Technology |
